Drug Metabolism Letters
Title:Meet Our Editorial Board Member:
Volume: 9 Issue: 2
Author(s): Albert P. Li
Affiliation:
Export Options
About this article
Cite this article as:
P. Li Albert, Meet Our Editorial Board Member:, Drug Metabolism Letters 2015; 9 (2) . https://dx.doi.org/10.2174/187231280902151027121549
DOI https://dx.doi.org/10.2174/187231280902151027121549 |
Print ISSN 1872-3128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-0758 |
Article Metrics
Related Articles
-
Neural Mechanisms of Exercise: Effects on Gut Miccrobiota and Depression
CNS & Neurological Disorders - Drug Targets Mechanisms of T Cell Receptor Antagonism: Implications in the Treatment of Disease
Current Molecular Medicine HCV and Autoimmunity
Current Pharmaceutical Design Shigella Vaccine Development: Prospective Animal Models and Current Status
Current Pharmaceutical Biotechnology Pharmacology of Nitric Oxide: Molecular Mechanisms and Therapeutic Strategies
Current Pharmaceutical Design Ulcerative Colitis: Pathogenesis
Current Drug Targets AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases
Current Gene Therapy Retinoid X Receptor Selective Agonists and their Synthetic Methods
Current Topics in Medicinal Chemistry Therapeutic Potential and Mechanisms of Action of Mesenchymal Stromal Cells for Acute Respiratory Distress Syndrome
Current Stem Cell Research & Therapy Polymeric Micelles for the Delivery of Diclofenac and Its Ethyl Ester Derivative
Pharmaceutical Nanotechnology Recent Developments of Amidine-like Compounds as Selective NOS Inhibitors
Current Enzyme Inhibition A Role for TGF-β Signaling in Neurodegeneration: Evidence from Genetically Engineered Models
Current Alzheimer Research Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Current Pharmaceutical Design Ectopic ATP Synthase in Endothelial Cells: A Novel Cardiovascular Therapeutic Target
Current Pharmaceutical Design Is Metformin a Therapeutic Paradigm for Colorectal Cancer: Insight into the Molecular Pathway?
Current Drug Targets Antioxidants and Mucolytics in COPD Management: When (if ever) and in Whom?
Current Drug Targets A Study of Applications of Machine Learning Based Classification Methods for Virtual Screening of Lead Molecules
Combinatorial Chemistry & High Throughput Screening Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets
Current Pharmaceutical Design Neural Network Alterations Across Eating Disorders: A Narrative Review of fMRI Studies
Current Neuropharmacology Targeting the Endocannabinod System to Limit Myocardial and Cerebral Ischemic and Reperfusion Injury
Current Pharmaceutical Biotechnology